clinical study of kanchanara and mundi kashaya in hypothyroidism

Analytical study and comparitive clinical efficacy of Kanchanara(Bauhinia variegata)twak vishoshi kashaya and Mundi(Sphaeranthus indicus)panchanga vishoshi kashaya in Hypothyroidism

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032630

Enrollment

Registered

2021-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: Bauhinia Variegata: Vishoshi Kashaya 24ML GIVEN ORALLY IN OD DOSE IN EMPTY STOMACH IN THE MORNING for 30days Control Intervention1: Sphaeranthus indicus: Vishoshi kashaya 24ML GIVEN ORA

Eligibility

Inclusion criteria

Inclusion criteria: -Patients already diagnosed as hypothyroidism without medication -Patients with primary hypothyroidism -Patients with subclinical hypothyroidism

Exclusion criteria

Exclusion criteria: -Patients who have undergone any type of thyroid surgery -Patients suffering from systemic diseases like IHD, PCOD, Diabetes Mellitus, Carcinoma, etc -Patients suffering from congenital hypothyroidism -Pregnant and lactating patients

Design outcomes

Primary

Measure	Time frame
Reduction of increased TSH levelsTimepoint: Day 0 Day 48	—

Secondary

Measure	Time frame
Improvement in subjective parameters like weight gain, appetite, menstrual disturbances, memory impairment, constipation, hairloss, etcTimepoint: Day 0 Day 48	—

Countries

India

Contacts

Public ContactDR PRASUSHA M

GOVERNMENT AYURVEDA MEDICAL COLLEGE BANGALORE

drlalithabr62@gmail.com9343707722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026